Can a simple training boost diabetes monitor use in underserved communities?

NCT ID NCT06638099

Knowledge-focused Sponsor: San Diego State University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether training healthcare providers to prescribe continuous glucose monitors (CGMs) increases their use among patients with type 2 diabetes. Researchers trained clinic staff at three community health centers serving a mostly Hispanic/Latino population. They then tracked CGM prescription rates and surveyed patients about their diabetes management and any barriers to using CGMs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: CGM prescription toolkit training for healthcare providers
What this could lead to: If successful, this training could help more patients with type 2 diabetes get access to continuous glucose monitors, potentially improving blood sugar control.
What could go wrong: This is a small, completed study in a single health system, so results may not apply elsewhere. It focuses on prescription rates, not long-term health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

195 people

The number who actually took part.

Started

Nov 2024

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Participant Eligibility: Inclusion: * adults 18 years or older, * have been diagnosed with T2D at least one year prior to recruitment, * are a current patient of one of the three participating Innercare Clinics with no - * plans to discontinue their care at Innercare within the next 6 months, * can understand and speak in English or Spanish, * have telephone access, * do not plan to move out of the area within the next 6 months. Exclusion: * Plans to move out of the area in the next 6 months * Patients with newly diagnose diabetes mellitus (less than one year), diabetes insipidus, diabetes type 1 or gestational diabetes. Provider/Staff Eligibility: Inclusion * 18 years or older, * able to read and write in English, * currently employed at one of the participating Innercare clinics (Brawley, El Centro, Calexico), * currently be treating at least one adult patient for T2D, scheduled to complete the CGM toolkit training. Exclusion * Personnel without experience providing care to adult patients with T2D in primary care settings.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes Diabetes mellitus Diabetes mellitus type 2 Diabetes mellitus type 2 (T2DM)

Can a simple training boost diabetes monitor use in underserved communities?

What the study statuses mean